Kymera Therapeutics, Inc. (KYMR)
Total Valuation
KYMR has a market cap or net worth of $1.04 billion. The enterprise value is $631.76 million.
| Market Cap | 1.04B |
| Enterprise Value | 631.76M |
Important Dates
The next earnings date is Friday, August 5, 2022, before market open.
| Estimated Earnings Date | Aug 5, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 51.72 million shares outstanding. The number of shares has increased by 15.68% in one year.
| Shares Outstanding | 51.72M |
| Shares Change (YoY) | +15.68% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 8.29% |
| Owned by Institutions (%) | 92.48% |
| Float | 34.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.43 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.88, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.88 |
| Quick Ratio | 4.83 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -30.40%, which is considered low. The company has a ROIC of -31.00%.
| Return on Equity (ROE) | -30.40% |
| Return on Assets (ROA) | -22.10% |
| Return on Capital (ROIC) | -31.00% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$865,916 |
| Employee Count | 143 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.30% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -55.30% |
| 50-Day Moving Average | 15.93 |
| 200-Day Moving Average | 36.25 |
| Average Volume (30 Days) | 754,556 |
Short Selling Information
The latest short interest is 4.92 million, so 9.51% of the outstanding shares have been sold short.
| Short Interest | 4.92M |
| Short % of Shares Out | 9.51% |
| Short % of Float | 14.34% |
| Short Ratio (days to cover) | 4.74 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -188.05M |
| Net Income | -123.83M |
| EBITDA | -121.04M |
| EBIT | -123.64M |
| Earnings Per Share (EPS) | -$2.49 |
Balance Sheet
The company has $426.92 million in cash and $17.47 million in debt, giving a net cash position of $409.45 million or $7.92 per share.
| Cash & Cash Equivalents | 426.92M |
| Total Debt | 17.47M |
| Net Cash | 409.45M |
| Net Cash Per Share | $7.92 |
| Book Value | 428.72M |
| Book Value Per Share | 8.29 |
| Working Capital | 343.04M |
Cash Flow
In the last 12 months, operating cash flow was -$146.42 million and capital expenditures -$1.92 million, giving a free cash flow of -$148.33 million.
| Operating Cash Flow | -146.42M |
| Capital Expenditures | -1.92M |
| Free Cash Flow | -148.33M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -11.89% |
| FCF Yield | -14.25% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.68% |
| Shareholder Yield | -15.68% |
Analyst Forecast
The average price target for KYMR is $64.34, which is 219.62% higher than the current price. The consensus rating is "Buy".
| Price Target | $64.34 |
| Price Target Difference | 219.62% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |